The DOI matches its Crossref record; 60 of the 61 references it cites were found in a registry or an index.
Long-term Effects of a Lifestyle Intervention on Weight and Cardiovascular Risk Factors in Individuals With Type 2 Diabetes Mellitus: Four-Year Results of the Look AHEAD Trial
Open accessAbstract
BACKGROUND: Lifestyle interventions produce short-term improvements in glycemia and cardiovascular disease (CVD) risk factors in individuals with type 2 diabetes mellitus, but no long-term data are available. We examined the effects of lifestyle intervention on changes in weight, fitness, and CVD risk factors during a 4-year study. METHODS: The Look AHEAD (Action for Health in Diabetes) trial is a multicenter randomized clinical trial comparing the effects of an intensive lifestyle intervention (ILI) and diabetes support and education (DSE; the control group) on the incidence of major CVD events in 5145 overweight or obese individuals (59.5% female; mean age, 58.7 years) with type 2 diabetes mellitus. More than 93% of participants provided outcomes data at each annual assessment. RESULTS: Averaged across 4 years, ILI participants had a greater percentage of weight loss than DSE participants (-6.15% vs -0.88%; P < .001) and greater improvements in treadmill fitness (12.74% vs 1.96%; P < .001), hemoglobin A(1c) level (-0.36% vs -0.09%; P < .001), systolic (-5.33 vs -2.97 mm Hg; P < .001) and diastolic (-2.92 vs -2.48 mm Hg; P = .01) blood pressure, and levels of high-density lipoprotein cholesterol (3.67 vs 1.97 mg/dL; P < .001) and triglycerides (-25.56 vs -19.75 mg/dL; P < .001). Reductions in low-density lipoprotein cholesterol levels were greater in DSE than ILI participants (-11.27 vs -12.84 mg/dL; P = .009) owing to greater use of medications to lower lipid levels in the DSE group. At 4 years, ILI participants maintained greater improvements than DSE participants in weight, fitness, hemoglobin A(1c) levels, systolic blood pressure, and high-density lipoprotein cholesterol levels. CONCLUSIONS: Intensive lifestyle intervention can produce sustained weight loss and improvements in fitness, glycemic control, and CVD risk factors in individuals with type 2 diabetes. Whether these differences in risk factors translate to reduction in CVD events will ultimately be addressed by the Look AHEAD trial. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT00017953.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Evidence of T2D remission beyond two years is sparse, with examples in bariatric surgery and following the three lifestyle interventions: 1) meal replacements for caloric restriction and physical activity [5,7,8]; 2) short-term total diet replacement with rescue therapy for weight maintenance [9]; and 3) a calorie-restricted Mediterranean diet [10].”
From 5-Year effects of a novel continuous remote care model with carbohydrate-restricted nutrition therapy including nutritional ketosis in type 2 diabetes: An extension study (2024) · cites this paper as [8]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“We previously reported improvements in glycemia, body weight, markers of liver disease and cardiovascular risk over two years among participants with T2D receiving a continuous care intervention (CCI) delivered via telemedicine by a care team who counseled participants on a very low carbohydrate diet including nutritional ketosis [8,19].”
From 5-Year effects of a novel continuous remote care model with carbohydrate-restricted nutrition therapy including nutritional ketosis in type 2 diabetes: An extension study (2024) · cites this paper as [8]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“the trajectory of outcomes in the usual care group followed for two years (showing no change in HbA1c and body weight concurrent with greater medication use [8])”
From 5-Year effects of a novel continuous remote care model with carbohydrate-restricted nutrition therapy including nutritional ketosis in type 2 diabetes: An extension study (2024) · cites this paper as [8]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“As comprehensive lifestyle treatment of overweight and obese adults with type 2 diabetes continues over 4 years, some weight regain will occur on average; partial weight regain is associated with an increase in hemoglobin A1c, but hemoglobin A1c remains below preintervention levels, and the reduction remains clinically meaningful.23”
From 2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society (2014) · cites this paper as [23]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Structured weight loss programs with regular visits and use of meal replacements have been shown to enhance weight loss in people with diabetes (138 -140).”
From Nutrition Therapy for Adults With Diabetes or Prediabetes: A Consensus Report (2019) · cites this paper as [140]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“It is well recognized among professional society guidelines that carbohydrate restricted nutrition therapy results in improved glycemia, most cardiovascular risk markers and reduced need for medication [11][12][13][14], yet current evidence is limited to two-years of follow-up [8,15,16,17,18].”
From 5-Year effects of a novel continuous remote care model with carbohydrate-restricted nutrition therapy including nutritional ketosis in type 2 diabetes: An extension study (2024) · cites this paper as [8]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“The slight increase in LDL-C encountered at one [19] and two years [8] (Fig. 2C) of the intervention regressed back to the baseline level at five years despite no significant changes in statin use, potentially reflecting the transient hypercholesterolemia associated with significant weight loss [31].”
From 5-Year effects of a novel continuous remote care model with carbohydrate-restricted nutrition therapy including nutritional ketosis in type 2 diabetes: An extension study (2024) · cites this paper as [8]
Experimental — accuracy not yet measuredIn the citing paper
“Structured weight loss programs with regular visits have been shown to enhance weight loss in T2DM [121,122,123].”
From Effects of diet, lifestyle, Chrononutrition and alternative dietary interventions on postprandial Glycemia and insulin resistance (2022) · cites this paper as [123]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873
(1998) · PsycEXTRA Dataset · doi:10.1037/e565682010-001 · Cited by 9,453
Effects of Bariatric Surgery on Mortality in Swedish Obese Subjects
Sjöström, L., Narbro, K., Sjöström, C. D., Karason, K., Larsson, B., Wedel, H., Lystig, T., Sullivan, M., Bouchard, C., Carlsson, B., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066254 · Cited by 4,668
Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery
Sjöström, L., Lindroos, A.-K., Peltonen, M., Torgerson, J., Bouchard, C., Carlsson, B., Dahlgren, S., Larsson, B., Narbro, K., Sjöström, C. D., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035622 · Cited by 4,457
Pan, X.-R., Li, G.-W., Hu, Y.-H., Wang, J.-X., Yang, W.-Y., An, Z.-X., Hu, Z.-X., Juan-Lin, Xiao, J.-Z., Cao, H.-B., et al. (1997) · Diabetes Care · doi:10.2337/diacare.20.4.537 · Cited by 4,320
Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
Frick, M. H., Elo, O., Haapa, K., Heinonen, O. P., Heinsalmi, P., Helo, P., Huttunen, J. K., Kaitaniemi, P., Koskinen, P., Manninen, V., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198711123172001 · Cited by 3,881
Rubins, H. B., Robins, S. J., Collins, D., Fye, C. L., Anderson, J. W., Elam, M. B., Faas, F. H., Linares, E., Schaefer, E. J., Schectman, G., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908053410604 · Cited by 3,439
(1998) · PubMed · Cited by 2,737
Flagged first, then by citations
1 of the 61 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- [13]Trials of Hypertension Prevention Collaborative Research Group Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high-normal blood pressure: The Trials of Hypertension Prevention, Phase II Arch Intern Med 1997 157 657 667 1997 9080920
Cited by
Sorted by citations
Items 301–400 of 1,001
Managing Overweight and Obesity in Adults to Reduce Cardiovascular Disease Risk
Ebbert, J. O., Elrashidi, M. Y., & Jensen, M. D. (2014) · Current Atherosclerosis Reports · doi:10.1007/s11883-014-0445-x · Cited by 52
Type 2 Diabetes in the Elderly: Challenges in a Unique Patient Population
Bradley, D. P. (2016) · Journal of Geriatric Medicine and Gerontology · doi:10.23937/2469-5858/1510014 · Cited by 59
Madjd, A., Taylor, M. A., Delavari, A., Malekzadeh, R., Macdonald, I. A., & Farshchi, H. R. (2015) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.115.109397 · Cited by 49
Barrea, L., Vetrani, C., Verde, L., Frías-Toral, E., Ceriani, F., Cernea, S., Docimo, A., Graziadio, C., Tripathy, D., Savastano, S., et al. (2023) · Antioxidants · doi:10.3390/antiox12040904 · Cited by 61
Sarvottam, K., & Yadav, R. K. (2014) · Europe PMC (PubMed Central) · Cited by 51
Naturopathic medicine for the prevention of cardiovascular disease: a randomized clinical trial
Seely, D., Szczurko, O., Cooley, K., Fritz, H., Aberdour, S., Herrington, C., Herman, P. M., Rouchotas, P., Lescheid, D. W., Bradley, R. D., et al. (2013) · Canadian Medical Association Journal · doi:10.1503/cmaj.120567 · Cited by 49
Phillips, A. S., & Guarnaccia, C. A. (2017) · Journal of Health Psychology · doi:10.1177/1359105317737606 · Cited by 47
Melmer, A., & Laimer, M. W. (2016) · Endocrine development · doi:10.1159/000439364 · Cited by 53
Bellavere, F., Cacciatori, V., Bacchi, E., Gemma, M. L., Raimondo, D., Negri, C., Thomaseth, K., Muggeo, M., Bonora, E., & Moghetti, P. (2018) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2017.12.008 · Cited by 48
Kempf, K., Kruse, J., & Martin, S. (2012) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2011.0116 · Cited by 48
The use of serotonergic drugs to treat obesity – is there any hope?
Bello, N. T., & Liang, N.-C. (2011) · Drug Design Development and Therapy · doi:10.2147/dddt.s11859 · Cited by 49
Lifestyle modification in the management of obesity: achievements and challenges
Grave, R. D., Calugi, S., & Ghoch, M. E. (2013) · Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity · doi:10.1007/s40519-013-0049-4 · Cited by 52
Obesity, Diabetes, the Cardiorenal Syndrome, and Risk for Cancer
Forte, V. A., Pandey, A. K., Abdelmessih, R. M., Forte, G., Whaley‐Connell, A. T., Sowers, J. R., & McFarlane, S. I. (2012) · Cardiorenal Medicine · doi:10.1159/000337314 · Cited by 50
Enricho Nkhoma, D., Jenya Soko, C., Joseph Banda, K., Greenfield, D., Li, Y.-C. (., & Iqbal, U. (2021) · BMJ Health & Care Informatics · doi:10.1136/bmjhci-2020-100291 · Cited by 46
Pepe, R. B., Lottenberg, A. M., Fujiwara, C. T. H., Beyruti, M., Cintra, D. E., Machado, R. M., Rodrigues, A., Jensen, N. S. O., Caldas, A. P. S., Fernandes, A. E., et al. (2023) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-023-01037-6 · Cited by 59
Dorsey, R. R., & Songer, T. J. (2011) · Europe PMC (PubMed Central) · Cited by 46
Kung, K., Chow, K. M., Hui, E. M., Leung, M. K. W., Leung, S. Y., Szeto, C., Lam, A. T., & Li, P. K. (2014) · BMC Family Practice · doi:10.1186/1471-2296-15-8 · Cited by 46
RetractedHansen, L. J., Siersma, V., Beck‐Nielsen, H., & Olivarius, N. D. F. (2013) · Diabetologia · doi:10.1007/s00125-013-2893-1 · Cited by 46
Foster, G. D., Wadden, T. A., Lagrotte, C. A., Veur, S. S. V., Hesson, L. A., Homko, C. J., Maschak-Carey, B. J., Barbor, N. R., Bailer, B. A., Diewald, L. K., et al. (2013) · Nutrition and Diabetes · doi:10.1038/nutd.2013.3 · Cited by 46
Sánchez, A. M. (2015) · American Journal of Public Health · doi:10.2105/ajph.2014.302507 · Cited by 47
Predictors of Improvement in Cardiometabolic Risk Factors With Weight Loss in Women
Dow, C. A., Thomson, C. A., Flatt, S. W., Sherwood, N. E., Pakiz, B., & Rock, C. L. (2013) · Journal of the American Heart Association · doi:10.1161/jaha.113.000152 · Cited by 47
Moncrieft, A. E., Llabre, M. M., McCalla, J. R., Gutt, M., Mendez, A. J., Gellman, M. D., Goldberg, R. B., & Schneiderman, N. (2016) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000348 · Cited by 50
Diabetes: An Update on the Pandemic and Potential Solutions
Ali, M. K., Siegel, K. R., Chandrasekar, E. K., Tandon, N., Montoya, P. A., Mbanya, J. C., Chan, J. C. N., Zhang, P., & Narayan, K. M. V. (2017) · World Bank, Washington, DC eBooks · doi:10.1596/978-1-4648-0518-9_ch12 · Cited by 45
Sergi, D., & Williams, L. M. (2019) · Nutrition Reviews · doi:10.1093/nutrit/nuz056 · Cited by 48
Niarchou, M., Byrne, E. M., Trzaskowski, M., Sidorenko, J., Kemper, K. E., McGrath, J. J., O’Donovan, M. C., Owen, M. J., & Wray, N. R. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-0688-y · Cited by 46
Mottalib, A., Sakr, M., Shehabeldin, M., & Hamdy, O. (2015) · Journal of Diabetes Research · doi:10.1155/2015/468704 · Cited by 44
Benefits and Risks for Intensive Glycemic Control in Patients With Diabetes Mellitus
Blonde, L. (2011) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e31823ea23e · Cited by 45
Kozlovskaia, M., Vlahovich, N., Rathbone, E. N., Manzanero, S., Keogh, J., & Hughes, D. C. (2017) · Health Promotion Journal of Australia · doi:10.1002/hpja.30 · Cited by 45
Yarborough, C. M., Brethauer, S. A., Burton, W. N., Fabius, R. J., Hymel, P. A., Kothari, S. N., Kushner, R. F., Morton, J. M., Mueller, K. L., Pronk, N. P., et al. (2018) · Journal of Occupational and Environmental Medicine · doi:10.1097/jom.0000000000001220 · Cited by 50
Molecular and cellular bases of diabetes: Focus on type 2 diabetes mouse model-TallyHo
Tamarai, K., Bhatti, J. S., & Reddy, P. H. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2019.05.004 · Cited by 48
Remission of Type 2 Diabetes with Very Low-Calorie Diets—A Narrative Review
Juray, S., Axen, K. V., & Trasino, S. E. (2021) · Nutrients · doi:10.3390/nu13062086 · Cited by 45
Efficacy of a mobile hypertension prevention delivery platform with human coaching
Toro-Ramos, T., Kim, Y., Wood, M., Rajda, J., Niejadlik, K., Honcz, J., Marrero, D., Fawer, A., & Michaelides, A. (2017) · Journal of Human Hypertension · doi:10.1038/jhh.2017.69 · Cited by 44
Lessons Learned: Experiences of Gaining Weight by Kidney Transplant Recipients
Stanfill, A. G., Bloodworth, R. F., & Cashion, A. K. (2012) · Progress in Transplantation · doi:10.7182/pit2012986 · Cited by 44
Ryan, J., Jennings, T. E., Vittoria, I., & Fedders, M. (2013) · Clinical Therapeutics · doi:10.1016/j.clinthera.2012.12.007 · Cited by 46
Evidence for the benefit of exercise therapy in patients with type 2 diabetes
Madden, K. M. (2013) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s32951 · Cited by 49
Motivational Interviewing for Weight Loss
DiLillo, V. G., & West, D. S. (2011) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2011.08.003 · Cited by 44
Wharton, S., Sharma, A. M., & Lau, D. C. W. (2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.01.025 · Cited by 44
Non‐pharmacological interventions in non‐alcoholic fatty liver disease patients
Ratziu, V. (2017) · Liver International · doi:10.1111/liv.13311 · Cited by 46
Long Term Impact of Intensive Lifestyle Intervention on Cerebral Blood Flow
Espeland, M., Luchsinger, J., Neiberg, R., Carmichael, O., Laurienti, P., Pi-Sunyer, X., Wing, R., Cook, D. R., Horton, E., Casanova, R., et al. (2017) · Journal of The American Geriatrics Society · doi:10.1111/jgs.15159 · Cited by 35
Pekkarinen, T., Kaukua, J., & Mustajoki, P. (2015) · Journal of Obesity · doi:10.1155/2015/651460 · Cited by 46
Hamdy, O., & Yusof, B. N. M. (2016) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2016.06.010 · Cited by 49
Obesity-induced changes in lipid mediators persist after weight loss
Hernandez, A. M., Weber, N., Frano, M. R. L., Ying, W., Lantero‐Rodriguez, J., Sears, D. D., Wallenius, V., Börgeson, E., Newman, J. W. I., & Osborn, O. (2017) · International Journal of Obesity · doi:10.1038/ijo.2017.266 · Cited by 44
Rådholm, K., Chalmers, J. P., Ohkuma, T., Peters, S. A. E., Poulter, N. R., Hamet, P., Harrap, S. B., & Woodward, M. (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13311 · Cited by 43
Nordyke, R. J., Appelbaum, K. J., & Berman, M. A. (2019) · Journal of Medical Internet Research · doi:10.2196/15814 · Cited by 43
A 2021 Update on the Use of Liraglutide in the Modern Treatment of ‘Diabesity’: A Narrative Review
Tilinca, M. C., Tiucă, R. A., Burlacu, A., & Varga, A. (2021) · Medicina · doi:10.3390/medicina57070669 · Cited by 45
Boye, K. S., Lage, M. J., Thieu, V. T., Shinde, S., Dhamija, S., & Bae, J. P. (2021) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2021.107975 · Cited by 43
on behalf of the ADDITION-Plus study team, Griffin, S. J., Simmons, R. K., Prevost, A. T., Williams, K. M., Hardeman, W., Sutton, S. R., Brage, S., Ekelund, U., Parker, R. A., et al. (2014) · Diabetologia · doi:10.1007/s00125-014-3236-6 · Cited by 43
Pharmacologic Treatment Options for Obesity: What Is Old Is New Again
Ryan, D. H., & Bray, G. A. (2013) · Current Hypertension Reports · doi:10.1007/s11906-013-0343-6 · Cited by 42
Byrne, H., Caulfield, B., & VITO, G. D. (2016) · Sports Medicine · doi:10.1007/s40279-016-0593-y · Cited by 43
Obesity, Type 2 Diabetes, and the Metabolic Syndrome
Genser, L., Mariolo, J. R. C., Castagneto‐Gissey, L., Panagiotopoulos, S., & Rubino, F. (2016) · Surgical Clinics of North America · doi:10.1016/j.suc.2016.03.013 · Cited by 47
Cardiovascular disease prevention strategies for type 2 diabetes mellitus
Katsiki, N., Purrello, F., Tsioufis, C. P., & Mikhailidis, D. P. (2017) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2017.1351946 · Cited by 42
RSSDI-ESI Clinical Practice Recommendations for the Management of Type 2 Diabetes Mellitus 2020
Chawla, R., Madhu, S. V., Makkar, B. M., Ghosh, S. K., Saboo, B., Kalra, S., & On behalf of RSSDI-ESI Consensus Group (2020) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-020-00819-2 · Cited by 44
Strategies to prevent weight gain in workplace and college settings: A systematic review
Gudzune, K. A., Hutfless, S. M., Maruthur, N. M., Wilson, R. F., & Segal, J. B. (2013) · Preventive Medicine · doi:10.1016/j.ypmed.2013.03.004 · Cited by 45
Associations between Depressive Symptoms and Incident ESRD in a Diabetic Cohort
Yu, M., Weiss, N. S., Ding, X., Katon, W. J., Zhou, X., & Young, B. A. (2014) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.08670813 · Cited by 41
Amendezo, E., Timothy, D. W., Karamuka, V., Robinson, B., Kavabushi, P., Ntirenganya, C., Uwiragiye, J., Mukantagwabira, D., Bisimwa, J., Marie, H. U., et al. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.02.001 · Cited by 44
Applying a technology‐based system for weight loss in adults with obesity
Rogers, R. J., Lang, W., Barone Gibbs, B., Davis, K. K., Burke, L. E., Kovacs, S. J., Portzer, L. A., & Jakicic, J. M. (2016) · Obesity Science & Practice · doi:10.1002/osp4.18 · Cited by 40
Li, D., Jia, L., Wu, X.-L., & Cheng, M. Y. (2025) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s508365 · Cited by 58
Epidemiology and Cardiovascular Benefits of Physical Activity and Exercise
Mi, M., Perry, A., Krishnan, V., & Nayor, M. G. (2025) · Circulation Research · doi:10.1161/circresaha.125.325526 · Cited by 58
Yank, V. A., Xiao, L., Wilson, S. R., Stafford, R. S., Rosas, L. G., & Ma, J. (2013) · Obesity · doi:10.1002/oby.20510 · Cited by 41
Naar‐King, S., Earnshaw, P., & Breckon, J. D. (2013) · Journal of Cognitive Psychotherapy · doi:10.1891/0889-8391.27.2.126 · Cited by 40
Comparative Effectiveness of Lifestyle Intervention Efforts in the Community
Piatt, G., Seidel, M. C., Powell, R. O., & Zgibor, J. C. (2012) · Diabetes Care · doi:10.2337/dc12-0824 · Cited by 43
Dasgupta, K., Hajna, S., Joseph, L., Da Costa, D., Christopoulos, S., & Gougeon, R. (2012) · International Journal of Behavioral Nutrition and Physical Activity · doi:10.1186/1479-5868-9-125 · Cited by 32
Trivedi, H., Gray, L. J., Seidu, S., Davies, M. J., Charpentier, G., Lindblad, U., Kellner, C., Nolan, J. J., Pazderska, A., Rutten, G. E. H. M., et al. (2017) · Primary care diabetes · doi:10.1016/j.pcd.2017.03.011 · Cited by 40
The Diagnosis and Management of Cerebrovascular Disease in Diabetes
Phipps, M., Jastreboff, A. M., Furie, K. L., & Kernan, W. N. (2012) · Current Diabetes Reports · doi:10.1007/s11892-012-0271-x · Cited by 43
Madjd, A., Taylor, M. A., Delavari, A., Malekzadeh, R., Macdonald, I. A., & Farshchi, H. R. (2017) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12793 · Cited by 39
Yeary, K. H. K., Cornell, C. E., Prewitt, T. E., Bursac, Z., Tilford, J. M., Turner, J. R., Eddings, K., Love, S. J., Whittington, E., & Harris, K. (2014) · Contemporary Clinical Trials · doi:10.1016/j.cct.2014.11.009 · Cited by 39
Vojta, D. D., Sa, J. M. D., Prospect, T., & Stevens, S. L. (2012) · Health Affairs · doi:10.1377/hlthaff.2011.0327 · Cited by 40
Legume Consumption and All-Cause and Cardiovascular Disease Mortality
Li, H., Li, J., Shen, Y., Wang, J., & Zhou, D. (2017) · BioMed Research International · doi:10.1155/2017/8450618 · Cited by 42
Katzmarzyk, P. T., Martin, C. K., Newton, R. L., Apolzan, J. W., Arnold, C. L., Davis, T. C., Denstel, K. D., Mire, E. F., Thethi, T. K., Brantley, P. J., et al. (2018) · Contemporary Clinical Trials · doi:10.1016/j.cct.2018.02.002 · Cited by 39
„Diabesity“ – Adipositas und Typ-2-Diabetes (Update 2019)
Toplak, H., Leitner, D. R., Harreiter, J., Hoppichler, F., Wascher, T. C., Schindler, K., & Ludvik, B. H. (2019) · Wiener klinische Wochenschrift · doi:10.1007/s00508-018-1418-9 · Cited by 39
Pot, G. K., Battjes‐Fries, M. C. E., Patijn, O. N., van der Zijl, N. J., Pijl, H., & Voshol, P. J. (2020) · BMJ Nutrition Prevention & Health · doi:10.1136/bmjnph-2020-000081 · Cited by 44
Espeland, M. A., Justice, J. N., Bahnson, J. L., Evans, J. K., Munshi, M. N., Hayden, K. M., Simpson, F. R., Johnson, K., Johnston, C. A., & Kritchevsky, S. B. (2021) · The Journals of Gerontology Series A · doi:10.1093/gerona/glab342 · Cited by 39
Behavioral Lifestyle Intervention in the Treatment of Obesity
Looney, S. M., & Raynor, H. A. (2013) · Health Services Insights · doi:10.4137/hsi.s10474 · Cited by 43
Berger, S. E., Huggins, G. S., McCaffery, J. M., Jacques, P. F., & Lichtenstein, A. H. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.118.010951 · Cited by 41
Windows of Opportunity for Lifestyle Interventions to Prevent Gestational Diabetes Mellitus
Phelan, S. (2016) · American Journal of Perinatology · doi:10.1055/s-0036-1586504 · Cited by 38
Christensen, P., Frederiksen, R., Bliddal, H., Riecke, B. F., Bartels, E. M., Henriksen, M., Juul‐S⊘rensen, T., Gudbergsen, H., Winther, K., Astrup, A. V., et al. (2013) · Obesity · doi:10.1002/oby.20413 · Cited by 38
Why do we need drugs to treat the patient with obesity?
Bray, G. A. (2013) · Obesity · doi:10.1002/oby.20394 · Cited by 40
Bennett, W. L., Gudzune, K. A., Appel, L. J., & Clark, J. M. (2013) · Journal of General Internal Medicine · doi:10.1007/s11606-013-2562-6 · Cited by 39
Managing Dyslipidemia in Type 2 Diabetes
Nelson, A. J., Rochelau, S. K., & Nicholls, S. J. (2017) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2017.10.004 · Cited by 38
Espeland, M. A., Carmichael, O. T., Hayden, K. M., Neiberg, R. H., Newman, A. B., Keller, J. N., Wadden, T. A., Rapp, S. R., Hill, J. O., Horton, E. S., et al. (2017) · The Journals of Gerontology Series A · doi:10.1093/gerona/glx165 · Cited by 38
Obesity in Pregnancy: ACOG Practice Bulletin, Number 230
Sagi‐Dain, L. (2021) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000004527 · Cited by 41
Kempf, K., Schloot, N. C., Gärtner, B., Keil, R., Schadewaldt, P., & Martin, S. (2013) · Journal of Human Nutrition and Dietetics · doi:10.1111/jhn.12145 · Cited by 38
Manuel, M., Lesmes, I. B., Marset, J. B., Izquierdo, J. Q. I., Formiguera, X., & Salas‐Salvadó, J. (2012) · PubMed · doi:10.3305/nh.2012.27.3.5680 · Cited by 40
Associations between age, cohort, and urbanization with SBP and DBP in China
Attard, S. M., Herring, A. H., Zhang, B., Du, S., Popkin, B. M., & Gordon‐Larsen, P. (2015) · Journal of Hypertension · doi:10.1097/hjh.0000000000000522 · Cited by 38
Yu, R., Yan, L. L., Wang, H., Ke, L., Yang, Z., Gong, E., Guo, H., Liu, J. H., Gu, Y., & Wu, Y. (2014) · Preventing Chronic Disease · doi:10.5888/pcd11.120333 · Cited by 37
Cost-effectiveness of a primary care intervention to treat obesity
Tsai, A. G., Wadden, T. A., Volger, S., Sarwer, D. B., Vetter, M., Kumanyika, S., Berkowitz, R. I., Diewald, L. K., Perez, J., Lavenberg, J., et al. (2013) · International Journal of Obesity · doi:10.1038/ijo.2013.94 · Cited by 37
Veldwijk, J., Lambooij, M., van Gils, P. F., Struijs, J. N., Smit, H. A., & de Wit, G. A. (2013) · BMC Public Health · doi:10.1186/1471-2458-13-1099 · Cited by 36
The obesity paradox – A reality that requires explanation and clinical interpretation
Dixon, J. B., & Lambert, G. W. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.11.005 · Cited by 37
Bradley, R. D., Sherman, K. J., Catz, S. L., Calabrese, C., Oberg, E. B., Jordan, L., Grothaus, L. C., & Cherkin, D. C. (2012) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-12-44 · Cited by 37
West, D. S., Harvey, J. R., Krukowski, R. A., Prewitt, T. E., Priest, J. S., & Ashikaga, T. (2016) · Obesity · doi:10.1002/oby.21645 · Cited by 37
Mai, K., Brachs, M., Leupelt, V., von Schwartzenberg, R. J., Maurer, L., Grüters‐Kieslich, A., Ernert, A., Bobbert, T., Krude, H., & Spranger, J. (2018) · Metabolism · doi:10.1016/j.metabol.2018.01.003 · Cited by 38
Non-alcoholic Fatty Liver Disease and Diabetes Mellitus
Khneizer, G. W., Rizvi, S., & Gawrieh, S. (2020) · Advances in experimental medicine and biology · doi:10.1007/5584_2020_532 · Cited by 41
Executive functions predict weight loss in a medically supervised weight loss programme
Galioto, R., Bond, D. S., Gunstad, J., Pera, V., Rathier, L. A., & Tremont, G. N. (2016) · Obesity Science & Practice · doi:10.1002/osp4.70 · Cited by 37
Making sense of metabolic obesity and hedonic obesity
Yu, Y. (2017) · Journal of Diabetes · doi:10.1111/1753-0407.12529 · Cited by 43
Glogner, S., Rosengren, A., Olsson, M., Gudbjörnsdottir, S., Svensson, A. ‐., & Lind, M. (2014) · Diabetic Medicine · doi:10.1111/dme.12340 · Cited by 33
Effects of different weight loss approaches on CVD risk
Clifton, P. M., & Keogh, J. B. (2018) · Current Atherosclerosis Reports · doi:10.1007/s11883-018-0728-8 · Cited by 36
Bond, D. S., O’Leary, K. C., Thomas, J. G., Lipton, R. B., Papandonatos, G. D., Roth, J. L., Rathier, L. A., Daniello, R., & Wing, R. R. (2013) · Contemporary Clinical Trials · doi:10.1016/j.cct.2013.03.004 · Cited by 37
Association between modifiable lifestyle factors and residual lifetime risk of diabetes
Djoussé, L., Driver, J. A., Gaziano, J. M., Buring, J. E., & Lee, I.-M. M. (2011) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2011.08.002 · Cited by 35
Jang, M., Johnson, C., D’Eramo-Melkus, G., & Vorderstrasse, A. A. (2017) · Journal of Transcultural Nursing · doi:10.1177/1043659617723074 · Cited by 35
Type 2 Diabetes Self-Management: Role of Diet Self-Efficacy
Strychar, I. M., Elisha, B., & Schmitz, N. (2012) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2012.10.005 · Cited by 40
Metadata
- Authors
- The Look AHEAD Research Group
- Affiliations
- Miriam Hospital (US)
- Corresponding author
- The Look AHEAD Research Group
- Venue
- Archives of Internal Medicine
- Publisher
- American Medical Association (AMA)
- Published
- 2010-09-27
- Volume
- 170
- Issue
- 17
- Pages
- 1566-75
- ISSN
- 0003-9926 (ISSN-L)
- PMC
- PMC3084497
- OpenAlex
- W1580839177
- Cited by
- 1,162
- References
- 61
- Citations by year
- 2026: 19 · 2025: 33 · 2024: 31 · 2023: 38 · 2022: 37 · 2021: 54 · 2020: 75 · 2019: 66 · 2018: 84 · 2017: 96 · 2016: 90 · 2015: 83 · 2014: 102 · 2013: 146 · 2012: 113
- FWCI
- 84.72
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Archives of Internal Medicine (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (5p30dk046204-15)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK-57171, DK 57136, DK57149, DK 57002, DK57182, DK56990, (DK 046204, DK57008, DK57177, DK 57078, DK57219, U01DK057149, DK-57178, U01DK057151, U01DK057135, U01DK057131, U01DK056990, DK-57135, U01DK057136, DK-56992, DK57154, U01DK057178, U01DK057182, U01DK057078, U01DK057154, P30DK079637, U01DK057008, U01DK057171, DK57131, U01DK057219, U01DK056992, U01DK057177, P30DK017047, P30DK048520, DK 57151, P30-DK 48520)
- National Center for Research Resources (M01-RR-0021140, M01RR-00051, M01RR002719, M01RR000056, M01RR01346, M01RR000051, M01RR001066, M01RR001346, UL1RR024153, M0-1-RR-02719, M01-RR01066)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Physical Activity and Health
- Keywords
- type 2 diabetes, intensive lifestyle intervention, weight loss, cardiovascular risk factors, glycemic control, HbA1c, blood pressure, HDL cholesterol, triglycerides, LDL cholesterol, diabetes support and education, Look AHEAD trial, long-term outcomes, overweight and obesity, cardiovascular disease prevention
- MeSH terms
- Aged, Blood Glucose, Blood Pressure, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Female, Humans, Life Style, Cholesterol, HDL, Cholesterol, LDL, Male, Middle Aged, Obesity, Patient Education as Topic, Physical Fitness, Risk Factors, Severity of Illness Index, Time Factors, Triglycerides, United States, Biomarkers, Weight Loss, Body Mass Index, Treatment Outcome, Diabetes Complications, Overweight
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
